Headlines from across medwireNews
21-10-2016 | Diabetes | News | Article
GLP-1 analogues unlikely to raise breast cancer risk
A study of women with Type 2 diabetes in the UK Clinical Practice Research Datalink suggests that use of glucagon-like peptide-1 analogues is unlikely to raise their risk of breast cancer – at least relative to the use of dipeptidylpeptidase-4 inhibitors.
21-10-2016 | HBV | News | Article
HBV variants limit NA therapy response
Detectable baseline mutations in the basal core promoter and/or precore regions of hepatitis B virus are associated with a reduced likelihood of hepatitis B surface antigen loss during long-term nucleos(t)ide analogue treatment, suggest researchers.
Beyond the news
medwireNews brings you news and conference reports from the ESMO 2016 Congress, held in Copenhagen, Denmark.
Click through to read the full reports of the latest research.
Highlights from the 1st conference of the European Academy of Neurology in Berlin, Germany.
Click through to read research news from the conference.
medwireNews is an established provider of authoritative, timely and independent medical news. We value your feedback and encourage you to contact us to make medwireNews.com your preferred medical news resource.
surgery11, Weight loss/© Alex Hinds / Fotolia.com, IV drip 2/© Anna Jurkovska / Fotolia, lung_cancer2, ESMO 2016 flags_enhanced/© Lynda Williams, Children with medical team/© Christopher Futcher, Brandenburg Gate/© Nikada/iStock, Lucy Piper, Lynda Williams, Eleanor McDermid, Shreeya Nanda, Claire Barnard, Alison Chapman, Kamran Ahmad